{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:00:58Z","timestamp":1791435658523,"version":"4.3.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.isci.2023.107631","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T06:02:29Z","timestamp":1692165749000},"page":"107631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response"],"prefix":"10.1016","volume":"26","author":[{"given":"Yining","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert J.","family":"Rottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Rose B.S.","family":"Crombag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maikel P.","family":"Peppelenbosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis E.","family":"Kainov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-6184","authenticated-orcid":false,"given":"Qiuwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2023.107631_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2023.107631_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10408363.2020.1860895","article-title":"COVID-19: from an acute to chronic disease? Potential long-term health consequences","volume":"58","author":"Higgins","year":"2021","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.isci.2023.107631_bib3","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2023.107631_bib4","doi-asserted-by":"crossref","first-page":"a041390","DOI":"10.1101\/cshperspect.a041390","article-title":"The Evolution and Biology of SARS-CoV-2 Variants","volume":"12","author":"Telenti","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.isci.2023.107631_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/infdis\/jiaa321","article-title":"Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context","volume":"222","author":"Li","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2023.107631_bib6","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jmv.26362","article-title":"More than just a common cold: Endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults","volume":"93","author":"Veiga","year":"2021","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.isci.2023.107631_bib7","doi-asserted-by":"crossref","first-page":"101085","DOI":"10.1016\/j.nmni.2023.101085","article-title":"Mpox-associated myopericarditis","volume":"51","author":"Al-Tawfiq","year":"2023","journal-title":"New Microbes New Infect."},{"key":"10.1016\/j.isci.2023.107631_bib8","doi-asserted-by":"crossref","first-page":"105555","DOI":"10.1016\/j.antiviral.2023.105555","article-title":"Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses","volume":"211","author":"Li","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.isci.2023.107631_bib9","doi-asserted-by":"crossref","first-page":"104112","DOI":"10.1016\/j.isci.2022.104112","article-title":"Mono- and combinational drug therapies for global viral pandemic preparedness","volume":"25","author":"Ianevski","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.isci.2023.107631_bib10","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2022.9925","article-title":"From Positive to Negative to Positive Again-The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid","volume":"327","author":"Rubin","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2023.107631_bib11","article-title":"COVID-19 Rebound after Paxlovid and Molnupiravir during January-June 2022","author":"Wang","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.isci.2023.107631_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tim.2017.01.001","article-title":"Transcriptional Regulation of Antiviral Interferon-Stimulated Genes","volume":"25","author":"Wang","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.isci.2023.107631_bib13","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.3390\/ijms24086887","article-title":"Therapeutic Effectiveness of Interferon-alpha2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience","volume":"24","author":"Kamyshnyi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2023.107631_bib14","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.3390\/v13122489","article-title":"Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections","volume":"13","author":"Ianevski","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2023.107631_bib15","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3390\/v13091768","article-title":"Nafamostat-Interferon-alpha Combination Suppresses SARS-CoV-2 Infection In\u00a0Vitro and In\u00a0Vivo by Cooperatively Targeting Host TMPRSS2","volume":"13","author":"Ianevski","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2023.107631_bib16","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1128\/JVI.03496-12","article-title":"Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus","volume":"87","author":"Zielecki","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2023.107631_bib17","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1073\/pnas.1320856111","article-title":"Interferon induction of IFITM proteins promotes infection by human coronavirus OC43","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2023.107631_bib18","doi-asserted-by":"crossref","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.isci.2023.107631_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.isci.2023.107631_bib20","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2023.107631_bib21","doi-asserted-by":"crossref","first-page":"104132","DOI":"10.1016\/j.ebiom.2022.104132","article-title":"Recapitulating infection, thermal sensitivity and antiviral treatment of seasonal coronaviruses in human airway organoids","volume":"81","author":"Li","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2023.107631_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nprot.2011.330","article-title":"A time-of-drug addition approach to target identification of antiviral compounds","volume":"6","author":"Daelemans","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2023.107631_bib23","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1126\/science.1224398","article-title":"Physiology. COX-2 inhibitors and cardiovascular risk","volume":"336","author":"Cannon","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.isci.2023.107631_bib24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41422-022-00618-w","article-title":"SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination","volume":"32","author":"Li","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2023.107631_bib25","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S2213-2600(21)00384-2","article-title":"Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial","volume":"9","author":"Kalil","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.isci.2023.107631_bib26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cmi.2022.04.016","article-title":"An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-beta-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results","volume":"28","author":"Ader","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.isci.2023.107631_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.it.2016.11.002","article-title":"Noncanonical Antiviral Mechanisms of ISGs: Dispensability of Inducible Interferons","volume":"38","author":"Xu","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2023.107631_bib28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/bmj.2.5363.965","article-title":"Indomethacin: A New Non-Steroid Anti-Inflammatory Agent","volume":"2","author":"Hart","year":"1963","journal-title":"Br. Med. J."},{"key":"10.1016\/j.isci.2023.107631_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/ard.29.4.393","article-title":"Evening indomethacin in the treatment of rheumatoid arthritis","volume":"29","author":"Huskisson","year":"1970","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2023.107631_bib30","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1128\/JVI.78.23.12964-12974.2004","article-title":"Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus","volume":"78","author":"Ray","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2023.107631_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10928-020-09690-4","article-title":"Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2","volume":"47","author":"Gomeni","year":"2020","journal-title":"J.\u00a0Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.isci.2023.107631_bib32","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/135965350601100803","article-title":"Indomethacin has a potent antiviral activity against SARS coronavirus","volume":"11","author":"Amici","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.isci.2023.107631_bib33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1572-0241.2005.41144.x","article-title":"Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial","volume":"100","author":"Bahrami","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.isci.2023.107631_bib34","doi-asserted-by":"crossref","first-page":"105788","DOI":"10.1016\/j.compbiomed.2022.105788","article-title":"In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2","volume":"147","author":"Chakraborty","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.isci.2023.107631_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/v13040558","article-title":"In\u00a0Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2","volume":"13","author":"Kiani","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2023.107631_bib36","doi-asserted-by":"crossref","first-page":"113814","DOI":"10.1016\/j.ejmech.2021.113814","article-title":"Indomethacin-based PROTACs as pan-coronavirus antiviral agents","volume":"226","author":"Desantis","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.isci.2023.107631_bib37","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/s41598-022-10370-1","article-title":"An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients","volume":"12","author":"Ravichandran","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2023.107631_bib38","doi-asserted-by":"crossref","first-page":"e0075","DOI":"10.1097\/HC9.0000000000000075","article-title":"The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population","volume":"7","author":"van Kleef","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.isci.2023.107631_bib39","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(22)01586-0","volume":"400","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2023.107631_bib40","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/ciac687","article-title":"Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalization in Community Coronavirus Disease 2019 Patients (COVID-19)","volume":"76","author":"Yip","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2023.107631_bib41","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2666-5247(22)00061-1","article-title":"Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations","volume":"3","author":"Li","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.isci.2023.107631_bib42","doi-asserted-by":"crossref","first-page":"1069894","DOI":"10.3389\/fimmu.2023.1069894","article-title":"Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis","volume":"14","author":"Buchynskyi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2023.107631_bib43","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/hep.24202","article-title":"Ribavirin enhances interferon-stimulated gene transcription by activation of the interferon-stimulated response element","volume":"53","author":"Pan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2023.107631_bib44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/ijms22020532","article-title":"Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics","volume":"22","author":"Terracciano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2023.107631_bib45","doi-asserted-by":"crossref","first-page":"eabe9403","DOI":"10.1126\/science.abe9403","article-title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms","volume":"370","author":"Gordon","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2023.107631_bib46","doi-asserted-by":"crossref","first-page":"e00014-21","DOI":"10.1128\/JVI.00014-21","article-title":"Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection","volume":"95","author":"Chen","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2023.107631_bib47","doi-asserted-by":"crossref","first-page":"e2000328","DOI":"10.1002\/ardp.202000328","article-title":"New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1\/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies","volume":"354","author":"Abdellatif","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.isci.2023.107631_bib48","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2023.107631_bib49","doi-asserted-by":"crossref","first-page":"eabo5400","DOI":"10.1126\/sciadv.abo5400","article-title":"Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection","volume":"8","author":"de Almeida","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2023.107631_bib50","doi-asserted-by":"crossref","first-page":"105475","DOI":"10.1016\/j.antiviral.2022.105475","article-title":"Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier","volume":"209","author":"Faist","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.isci.2023.107631_bib51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijid.2020.02.018","article-title":"Discovery and development of safe-in-man broad-spectrum antiviral agents","volume":"93","author":"Andersen","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.isci.2023.107631_bib52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2018.04.016","article-title":"Novel activities of safe-in-human broad-spectrum antiviral agents","volume":"154","author":"Ianevski","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.isci.2023.107631_bib53","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41586-020-2922-4","article-title":"A molecular cell atlas of the human lung from single-cell RNA sequencing","volume":"587","author":"Travaglini","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2023.107631_bib54","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422301708X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422301708X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T22:18:51Z","timestamp":1738880331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258900422301708X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S258900422301708X"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2023.107631","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2023.107631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"107631"}}